Labcorp Holdings Inc. insider trading
LHfinancial statementsForm 4 filings on EDGAR306 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Labcorp Holdings Inc. bought $0 of stock in the open market, and 3 sold $3M. Officers and directors accounted for $0 of purchases and $3M of sales. The last reported transaction was an open-market sale by Anderson Kerrii B on August 17, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 18, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $3MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
306 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Anderson Kerrii B | Director | open-market sale10b5-1 | 3,000 | $318.02 | $954K | 6,563 | Aug 18, 2026 |
| Aug 11, 2026 | Schechter Adam H | President & CEO, Director | open-market sale10b5-1 | 4,669 | $320.37 | $1M | 102,565 | Aug 12, 2026 |
| Aug 4, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | open-market sale | 924 | $306.74 | $283K | 6,956 | Aug 6, 2026 |
| Aug 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | open-market sale | 82 | $309.22 | $25K | 1,770 | Aug 5, 2026 |
| Aug 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | option exercise | 1,338 | $209.25 | $280K | 3,108 | Aug 5, 2026 |
| Aug 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | open-market sale | 1,338 | $309.23 | $414K | 1,770 | Aug 5, 2026 |
| Jul 2, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | open-market sale10b5-1 | 92 | $286.19 | $26K | 3,904 | Jul 6, 2026 |
| Jul 2, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | open-market sale10b5-1 | 234 | $286.19 | $67K | 6,746 | Jul 6, 2026 |
| Jul 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | option exercise | 256 | — | — | 4,069 | Jul 6, 2026 |
| Jul 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | tax withholding | 73 | $283.88 | $21K | 3,996 | Jul 6, 2026 |
| Jul 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | option exercise | 327 | — | — | 7,073 | Jul 6, 2026 |
| Jul 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | tax withholding | 93 | $283.88 | $26K | 6,980 | Jul 6, 2026 |
| Jun 8, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | open-market sale10b5-1 | 762 | $263.89 | $201K | 3,813 | Jun 10, 2026 |
| May 11, 2026 | Schechter Adam H | President & CEO, Director | open-market sale10b5-1 | 5,903 | $254.50 | $2M | 107,234 | May 13, 2026 |
| Mar 27, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | open-market sale10b5-1 | 1,633 | $267.05 | $436K | 1,852 | Mar 30, 2026 |
| Mar 27, 2026 | Meltzer Jonathan C | EVP, Operations | open-market sale10b5-1 | 839 | $267.05 | $224K | 3,620 | Mar 30, 2026 |
| Mar 27, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | open-market sale10b5-1 | 1,633 | $267.05 | $436K | 1,852 | Mar 30, 2026 |
| Mar 27, 2026 | Meltzer Jonathan C | EVP, Operations | open-market sale10b5-1 | 839 | $267.05 | $224K | 3,620 | Mar 30, 2026 |
| Mar 26, 2026 | Schechter Adam H | President & CEO, Director | tax withholding | 26,106 | $268.38 | $7M | 113,137 | Mar 30, 2026 |
| Mar 26, 2026 | Schechter Adam H | President & CEO, Director | award | 58,470 | $0.00 | — | 139,243 | Mar 30, 2026 |
| Mar 26, 2026 | Graham Anita Z | EVP, CHRO | award | 6,604 | $0.00 | — | 8,064 | Mar 30, 2026 |
| Mar 26, 2026 | Graham Anita Z | EVP, CHRO | tax withholding | 2,879 | $268.38 | $773K | 5,185 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | tax withholding | 1,468 | $268.38 | $394K | 12,677 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | award | 2,968 | $0.00 | — | 14,145 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | tax withholding | 4,600 | $268.38 | $1M | 11,177 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | award | 9,304 | $0.00 | — | 15,777 | Mar 30, 2026 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | award | 9,304 | $0.00 | — | 39,411 | Mar 30, 2026 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | tax withholding | 4,042 | $268.38 | $1M | 35,369 | Mar 30, 2026 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | award | 1,986 | $0.00 | — | 37,355 | Mar 30, 2026 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | tax withholding | 863 | $268.38 | $232K | 36,492 | Mar 30, 2026 |
| Mar 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | tax withholding | 755 | $268.38 | $203K | 3,485 | Mar 30, 2026 |
| Mar 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | award | 2,388 | $0.00 | — | 4,240 | Mar 30, 2026 |
| Mar 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | award | 1,584 | $0.00 | — | 7,197 | Mar 30, 2026 |
| Mar 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | tax withholding | 451 | $268.38 | $121K | 6,746 | Mar 30, 2026 |
| Mar 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | award | 6,382 | $0.00 | — | 8,961 | Mar 30, 2026 |
| Mar 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | tax withholding | 2,722 | $268.38 | $731K | 6,239 | Mar 30, 2026 |
| Mar 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | award | 3,994 | $0.00 | — | 9,716 | Mar 30, 2026 |
| Mar 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | tax withholding | 1,836 | $268.38 | $493K | 7,880 | Mar 30, 2026 |
| Mar 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | award | 1,340 | $0.00 | — | 5,446 | Mar 30, 2026 |
| Mar 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | tax withholding | 382 | $268.38 | $103K | 5,064 | Mar 30, 2026 |
| Mar 26, 2026 | Meltzer Jonathan C | EVP, Operations | award | 2,388 | $0.00 | — | 5,170 | Mar 30, 2026 |
| Mar 26, 2026 | Meltzer Jonathan C | EVP, Operations | tax withholding | 711 | $268.38 | $191K | 4,459 | Mar 30, 2026 |
| Mar 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | award | 1,584 | $0.00 | — | 5,026 | Mar 30, 2026 |
| Mar 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | tax withholding | 451 | $268.38 | $121K | 4,575 | Mar 30, 2026 |
| Mar 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | tax withholding | 481 | $268.38 | $129K | 4,851 | Mar 30, 2026 |
| Mar 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | award | 1,184 | $0.00 | — | 5,332 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | award | 9,304 | $0.00 | — | 15,777 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | tax withholding | 4,600 | $268.38 | $1M | 11,177 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | award | 2,968 | $0.00 | — | 14,145 | Mar 30, 2026 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | tax withholding | 1,468 | $268.38 | $394K | 12,677 | Mar 30, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Schechter Adam H | President & CEO, Director | Aug 11, 2026 | open-market sale | 102,565 | — | $8M (5) | 4 of 5 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 3, 2026 | open-market sale | 1,770 | — | $1M (5) | 3 of 5 |
| Anderson Kerrii B | Director | Aug 17, 2026 | open-market sale | 6,563 | — | $954K (1) | 1 of 1 |
| Meltzer Jonathan C | EVP, Operations | Mar 27, 2026 | open-market sale | 3,620 | — | $523K (5) | 5 of 5 |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | Mar 26, 2026 | award | 39,411 | — | $429K (1) | 0 of 1 |
| Summy Amy B. | EVP, Chief Marketing Officer | Aug 4, 2026 | open-market sale | 6,956 | — | $283K (1) | 0 of 1 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 2, 2026 | open-market sale | 3,904 | — | $227K (2) | 2 of 2 |
| van der Vaart Sandra D | EVP, Corporate Affairs | Mar 26, 2026 | award | 8,961 | — | $156K (1) | 0 of 1 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 2, 2026 | open-market sale | 6,746 | — | $67K (1) | 1 of 1 |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | Mar 26, 2026 | tax withholding | 12,677 | — | — | — |
| Bailey Megan D. | EVP, Pres, Central Labs & Intl | Mar 26, 2026 | tax withholding | 4,851 | — | — | — |
| Oyegunwa Akinbolade | EVP, CIO & CTO | Mar 26, 2026 | award | 5,446 | — | — | — |
| Graham Anita Z | EVP, CHRO | Mar 26, 2026 | award | 8,064 | — | — | — |
| Eisenberg Glenn A | Executive Vice President | Mar 27, 2025 | tax withholding | 37,920 | — | — | — |
| Berberian Lance | EVP, Special Advisor, Strategy | Mar 27, 2025 | tax withholding | 18,652 | — | — | — |
| Wang Julia Aijun | Chief Financial Officer, EVP | Feb 11, 2026 | option exercise | 2,062 | — | — | — |
| Parham Richelle P | Director | Feb 11, 2026 | option exercise | 3,366 | — | — | — |
| Gilliland Dwight Gary | Director | Jul 30, 2025 | open-market sale | 6,656 | — | — | — |
| Rothman Paul | Director | Feb 11, 2026 | option exercise | 2,571 | — | — | — |
| Wengel Kathryn E | Director | Feb 11, 2026 | option exercise | 4,133 | — | — | — |
| Neupert Peter M | Director | Feb 11, 2026 | option exercise | 13,784 | — | — | — |
| Kong Garheng | Director | Feb 11, 2026 | option exercise | 13,739 | — | — | — |
| Kliphouse Kirsten Marie | Director | Feb 11, 2026 | option exercise | 3,160 | — | — | — |
| Davis Jeffrey A. | Director | Feb 11, 2026 | option exercise | 5,460 | — | — | — |
Questions
Are Labcorp Holdings Inc. insiders buying or selling?
Over the twelve months to November 1, 2026, 9 insiders at Labcorp Holdings Inc. sold $13M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $13M. Only open-market purchases and sales are counted.
Who sold the most Labcorp Holdings Inc. stock in the last year?
Schechter Adam H (President & CEO, Director) sold $8M in 5 open-market sales over the twelve months to November 1, 2026.
Do Labcorp Holdings Inc. executives sell under 10b5-1 plans?
16 of the 22 open-market sales in the last twelve months (73%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Labcorp Holdings Inc.
- Labcorp Holdings Inc. financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.